A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia

Clinical trial NCT07693777 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07693777
Sponsor: Zhejiang Doer Biologics Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Hypertriglyceridemia (sHTG)Hypertriglyceridemia

Start date: 2026-08-17
Primary completion: 2029-02-14
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.